{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Zhang C"],"pubmed_abstract":["<h4>Backgrounds</h4>Trimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC) is associated with a significant survival benefit. Modified Ryan score is an effective tool to evaluated the tumor regression grade (TRG) after neoadjuvant therapy. The aim of this study was to evaluate the prognostic value of TRG for overall survival (OS) and disease-free survival (DFS) in ESCC patients undergoing neoadjuvant chemoradiation.<h4>Methods</h4>The study retrospectively reviewed 523 ESCC patients who underwent neoadjuvant chemoradiotherapy and radical esophagectomy at Jinling Hospital from January 2014 to July 2020. Kaplan-Meier curves with log-rank test and Cox regression model were used to evaluate the prognostic factor"],"journal":["Frontiers in surgery"],"pagination":["1029575"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9852042"],"repository":["biostudies-literature"],"pubmed_title":["Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation."],"pmcid":["PMC9852042"],"pubmed_authors":["Hu LW","Cong ZZ","Wang Q","Zhang Z","Xu F","Qiang Y","Qiu BM","Zhang C","Luo C","Shen Y"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation.","description":"<h4>Backgrounds</h4>Trimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC) is associated with a significant survival benefit. Modified Ryan score is an effective tool to evaluated the tumor regression grade (TRG) after neoadjuvant therapy. The aim of this study was to evaluate the prognostic value of TRG for overall survival (OS) and disease-free survival (DFS) in ESCC patients undergoing neoadjuvant chemoradiation.<h4>Methods</h4>The study retrospectively reviewed 523 ESCC patients who underwent neoadjuvant chemoradiotherapy and radical esophagectomy at Jinling Hospital from January 2014 to July 2020. Kaplan-Meier curves with log-rank test and Cox regression model were used to evaluate the prognostic factor","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-06T09:46:54.993Z","creation":"2025-04-06T09:46:54.993Z"},"accession":"S-EPMC9852042","cross_references":{"pubmed":["36684331"],"doi":["10.3389/fsurg.2022.1029575"]}}